Christopher S. Henney - 25 Jun 2021 Form 4 Insider Report for PROTHENA CORP PUBLIC LTD CO (PRTA)

Role
Director
Signature
/s/ Karin L. Walker, as Attorney in Fact for Christopher Henney
Issuer symbol
PRTA
Transactions as of
25 Jun 2021
Net transactions value
-$375,659
Form type
4
Filing time
29 Jun 2021, 18:13:10 UTC
Previous filing
17 Jun 2021
Next filing
13 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRTA Ordinary Shares, par value $0.01 per share Options Exercise $197,160 +12,000 $16.43 12,000 25 Jun 2021 Direct
transaction PRTA Ordinary Shares, par value $0.01 per share Sale $488,223 -10,264 -86% $47.57 1,736 25 Jun 2021 Direct F1
transaction PRTA Ordinary Shares, par value $0.01 per share Sale $84,597 -1,736 -100% $48.73 0 25 Jun 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRTA Stock Option (Right to Buy) Options Exercise $0 +12,000 $0.000000* 0 25 Jun 2021 Ordinary Shares 12,000 $16.43 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was executed in multiple trades in prices ranging from $47.18 to $48.17, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F2 The transaction was executed in multiple trades in prices ranging from $48.23 to $49.14, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 The shares subject to the option were fully vested as of the date of the exercise.